Canada markets closed

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3320-0.0531 (-13.79%)
At close: 04:00PM EDT
0.3525 +0.02 (+6.17%)
After hours: 07:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.60M
Enterprise Value 15.84M
Trailing P/E 0.78
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)192.64
Price/Book (mrq)N/A
Enterprise Value/Revenue 220.46
Enterprise Value/EBITDA -0.42

Trading Information

Stock Price History

Beta (5Y Monthly) 1.90
52-Week Change 3-98.37%
S&P500 52-Week Change 321.61%
52 Week High 349.8000
52 Week Low 30.3311
50-Day Moving Average 30.7940
200-Day Moving Average 312.2905

Share Statistics

Avg Vol (3 month) 3434.21k
Avg Vol (10 day) 3406.9k
Shares Outstanding 513.68M
Implied Shares Outstanding 613.68M
Float 813.4M
% Held by Insiders 12.00%
% Held by Institutions 121.74%
Shares Short (Mar 28, 2024) 4726.81k
Short Ratio (Mar 28, 2024) 41.31
Short % of Float (Mar 28, 2024) 45.42%
Short % of Shares Outstanding (Mar 28, 2024) 45.31%
Shares Short (prior month Feb 29, 2024) 4292.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 24, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Nov 28, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,226.80%

Management Effectiveness

Return on Assets (ttm)-179.75%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.2M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-37.88M
Diluted EPS (ttm)-7.7300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3M
Total Cash Per Share (mrq)0.22
Total Debt (mrq)14.23M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.14
Book Value Per Share (mrq)-3.42

Cash Flow Statement

Operating Cash Flow (ttm)-23.91M
Levered Free Cash Flow (ttm)-5.11M